DK166502B1 - 13alfa-methyl-17beta-(3-acyloxypropyl)-gonaner, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af laegemidler - Google Patents
13alfa-methyl-17beta-(3-acyloxypropyl)-gonaner, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af laegemidler Download PDFInfo
- Publication number
- DK166502B1 DK166502B1 DK587585A DK587585A DK166502B1 DK 166502 B1 DK166502 B1 DK 166502B1 DK 587585 A DK587585 A DK 587585A DK 587585 A DK587585 A DK 587585A DK 166502 B1 DK166502 B1 DK 166502B1
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- methyl
- gonanes
- acyloxypropyl
- 13alfa
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 title description 2
- 239000003814 drug Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 1
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- -1 3-hydroxypropyl compounds Chemical class 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- YVHAIVPPUIZFBA-UHFFFAOYSA-N Cyclopentylacetic acid Chemical compound OC(=O)CC1CCCC1 YVHAIVPPUIZFBA-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- GRXPVLPQNMUNNX-SDJHSENKSA-N (8R,9R,10S,13R,14S)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthrene Chemical class C[C@@]12CCC[C@H]2[C@H]2[C@H](CC1)[C@H]1CCCCC1CC2 GRXPVLPQNMUNNX-SDJHSENKSA-N 0.000 description 1
- FBRJYBGLCHWYOE-UHFFFAOYSA-N 2-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(F)(F)F FBRJYBGLCHWYOE-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003418 antiprogestin Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 229940086542 triethylamine Drugs 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3446661 | 1984-12-18 | ||
DE19843446661 DE3446661A1 (de) | 1984-12-18 | 1984-12-18 | Neue 13(alpha)-alkyl-17(beta)-(3-acyloxypropyl)-gonane |
Publications (3)
Publication Number | Publication Date |
---|---|
DK587585D0 DK587585D0 (da) | 1985-12-17 |
DK587585A DK587585A (da) | 1986-06-19 |
DK166502B1 true DK166502B1 (da) | 1993-06-01 |
Family
ID=6253403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK587585A DK166502B1 (da) | 1984-12-18 | 1985-12-17 | 13alfa-methyl-17beta-(3-acyloxypropyl)-gonaner, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af laegemidler |
Country Status (17)
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4434488A1 (de) * | 1994-09-14 | 1996-03-21 | Schering Ag | Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
DE3461090D1 (en) * | 1983-02-18 | 1986-12-04 | Schering Ag | 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them |
ES533260A0 (es) * | 1983-06-15 | 1985-02-01 | Schering Ag | Procedimiento para la preparacion de 13a-alquilgonanos |
-
1984
- 1984-12-18 DE DE19843446661 patent/DE3446661A1/de not_active Withdrawn
-
1985
- 1985-12-03 FI FI854788A patent/FI83089C/fi not_active IP Right Cessation
- 1985-12-05 NZ NZ214449A patent/NZ214449A/xx unknown
- 1985-12-13 DE DE8585115925T patent/DE3572670D1/de not_active Expired
- 1985-12-13 AT AT85115925T patent/ATE45957T1/de not_active IP Right Cessation
- 1985-12-13 EP EP85115925A patent/EP0186834B1/de not_active Expired
- 1985-12-16 GR GR853017A patent/GR853017B/el unknown
- 1985-12-16 ES ES549998A patent/ES8701194A1/es not_active Expired
- 1985-12-16 DD DD85284398A patent/DD242231A5/de not_active IP Right Cessation
- 1985-12-16 IE IE316985A patent/IE58147B1/en not_active IP Right Cessation
- 1985-12-17 CA CA000497807A patent/CA1262894A/en not_active Expired
- 1985-12-17 JP JP60282175A patent/JPH0662665B2/ja not_active Expired - Lifetime
- 1985-12-17 NO NO855090A patent/NO163014C/no unknown
- 1985-12-17 PT PT81690A patent/PT81690B/pt not_active IP Right Cessation
- 1985-12-17 DK DK587585A patent/DK166502B1/da not_active IP Right Cessation
- 1985-12-17 HU HU854813A patent/HU193357B/hu not_active IP Right Cessation
- 1985-12-18 AU AU51436/85A patent/AU580646B2/en not_active Ceased
- 1985-12-18 ZA ZA859666A patent/ZA859666B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA1262894A (en) | 1989-11-14 |
FI83089B (fi) | 1991-02-15 |
HU193357B (en) | 1987-09-28 |
PT81690A (de) | 1986-01-01 |
JPS61145197A (ja) | 1986-07-02 |
NO163014C (no) | 1990-03-21 |
NO855090L (no) | 1986-06-19 |
NO163014B (no) | 1989-12-11 |
EP0186834A2 (de) | 1986-07-09 |
HUT40138A (en) | 1986-11-28 |
ES549998A0 (es) | 1986-12-01 |
JPH0662665B2 (ja) | 1994-08-17 |
GR853017B (enrdf_load_stackoverflow) | 1986-04-15 |
DE3446661A1 (de) | 1986-06-19 |
DD242231A5 (de) | 1987-01-21 |
FI854788L (fi) | 1986-06-19 |
EP0186834A3 (en) | 1986-11-26 |
ES8701194A1 (es) | 1986-12-01 |
IE853169L (en) | 1986-06-18 |
IE58147B1 (en) | 1993-07-14 |
ZA859666B (en) | 1986-08-27 |
FI854788A0 (fi) | 1985-12-03 |
DK587585A (da) | 1986-06-19 |
DE3572670D1 (de) | 1989-10-05 |
FI83089C (fi) | 1991-05-27 |
DK587585D0 (da) | 1985-12-17 |
EP0186834B1 (de) | 1989-08-30 |
PT81690B (pt) | 1988-02-17 |
NZ214449A (en) | 1989-01-06 |
ATE45957T1 (de) | 1989-09-15 |
AU5143685A (en) | 1986-06-26 |
AU580646B2 (en) | 1989-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2183589A (en) | Derivatives of compounds of the | |
US4780461A (en) | 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same | |
Barczai-Martos et al. | Preparation of acetobrome-sugars | |
US3965128A (en) | 6β,7β-Epoxy-1α,2α-methylen-D-homo-4-pregnen-3,20-diones | |
US3318926A (en) | 7alpha-methyl-16alpha-hydroxy-estrones | |
DK166502B1 (da) | 13alfa-methyl-17beta-(3-acyloxypropyl)-gonaner, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af laegemidler | |
DE69302726T2 (de) | Neue Steroide mit einer an der 17-Stelle spiro-kondensierte Methylen-Laktongruppe, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und pharmazeutische Präparate davon | |
DE3506100A1 (de) | 1(alpha).7(alpha)-dithiosubstituierte spirolactone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
US2708201A (en) | 16-haloprogesterones, their 21-hydroxy derivatives and esters thereof | |
US4331663A (en) | 4α,5α-Epoxy-3,20-dioxopregnane-2α,16α-dicarbonitrile and intermediates and process for preparation, method of use and compositions thereof | |
US3261852A (en) | Adamantoate esters of testosterone | |
US3311613A (en) | Derivatives of glycyrrhetinic acid and process for the preparation thereof | |
US3185713A (en) | 12-keto progestational steroids and derivatives thereof | |
US2926167A (en) | Process of esterifying ib-hydroxy | |
US3743660A (en) | 17-sulfo-acetates of estradiol | |
US2904551A (en) | Chemical compounds and processes of preparing the same | |
US2864839A (en) | delta4, 7, 9(11)-pregnatriene-17alpha, 21-diol-3, 20-dione and process therefor | |
US3337569A (en) | Method of producing o-nicotinoylcholine chloride | |
US3277123A (en) | 16beta-lower alkylthio-17beta-hydroxy-estren-3-one and production thereof | |
US3025312A (en) | 9alpha, 11beta-dichloro pregnanes | |
US2921064A (en) | 6, 7-dihydroxy estradiol and intermediates thereof | |
US3522281A (en) | Delta**3,5-7alpha-methyloestradienes | |
NO119469B (enrdf_load_stackoverflow) | ||
US2931808A (en) | 16-cyano-5-pregnene-3, 20-diol and derivatives | |
US3452057A (en) | 2-hydroxy methyleneandrostanes and esters thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |